Axsome Therapeutics(DE:19X)
€125.15+0.25 (+0.20%)
DE:19X
Axsome Therapeutics earnings date
€125.15
At close:+0.25 (+0.20%)
Axsome Therapeutics (19X) Q1 2024 Earnings Report
5 Followers
DE:19X Q1 2024 EPS Results
- Actual EPS
- -EUR 1.31
- Consensus EPS
- -EUR 1.09
- Beat/Miss
- Missed by -EUR 0.21
- One Year Ago EPS
- -EUR 0.24
DE:19X Q1 2024 Revenue Results
- Actual Revenue
- EUR 68.04M
- Expected Revenue
- EUR 66.49M
- Beat/Miss
- Beat by +EUR 1.55M
- YoY Revenue Growth
- -20.70%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 05/06/2024
- Time
- Before Open
- Conference Call
- Monday, May 6, 2024
DE:19X Upcoming Earnings
Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q1 2024 Earnings Call Audio
DE:19X Q1 2024 Earnings Call
0:00 / 0:00
Q1 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:19X Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.05- | -0.51 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.58-0.23 | -0.85 | 73.40% (+0.63) | |
| Aug 10, 2026 | 2026 (Q2) | -0.81-0.90 | -0.88 | -2.06% (-0.02) | |
| May 04, 2026 | 2026 (Q1) | -0.77-1.14 | -1.11 | -3.28% (-0.04) | |
| Feb 23, 2026 | 2025 (Q4) | -0.63-0.51 | -1.4 | 63.64% (+0.89) | |
| Nov 03, 2025 | 2025 (Q3) | -0.78-0.85 | -1.22 | 29.85% (+0.36) | |
| Aug 04, 2025 | 2025 (Q2) | -0.96-0.88 | -1.52 | 41.92% (+0.64) | |
| May 05, 2025 | 2025 (Q1) | -1.23-1.11 | -1.31 | 15.28% (+0.20) | |
| Feb 18, 2025 | 2024 (Q4) | -0.91-1.40 | -1.89 | 25.96% (+0.49) | |
| Nov 12, 2024 | 2024 (Q3) | -1.25-1.22 | -1.2 | -1.52% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

